An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples

References

• Moore K, Roberts LJ, 2nd. Measurement of lipid peroxidation. Free Radic Res 1998;28:659–671.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129–135.
   PubMed Web of Science ®Google Scholar
• Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009;47: 469–484.
   PubMed Web of Science ®Google Scholar
• Birukov KG. Oxidized lipids: the two faces of vascular inflammation. Curr Atheroscler Rep 2006;8:223–231.
   PubMedGoogle Scholar
• Salomon RG. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis. Ann NY Acad Sci 2005;1043: 327–342.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601–623.
   PubMed Web of Science ®Google Scholar
• Spiteller G. Is atherosclerosis a multifactorial disease or is it induced by a sequence of lipid peroxidation reactions? Ann NY Acad Sci 2005;1043:355–366.
   PubMed Web of Science ®Google Scholar
• Stocker R, Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381–1478.
   PubMed Web of Science ®Google Scholar
• Basu S. F-2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Sign 2008;10:1405–1434.
   PubMed Web of Science ®Google Scholar
• Milne GL, Musiek ES, Morrow JD. F-2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005;10:S10–S23.
   Web of Science ®Google Scholar
• Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. Faseb Journal 2004;18: 1791–1800.
   PubMed Web of Science ®Google Scholar
• Griffiths HR, Olinski R, Coolen S, Collins A, Astley SB. Biomarkers. Free Radic Res 2002:36:7–8.
   Web of Science ®Google Scholar
• Roberts LJ, Morrow JD. Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505–513.
   PubMed Web of Science ®Google Scholar
• Spickett CM, Wiswedel I, Siems W, Zarkovic K, Zarkovic N. Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res 2010; in press.
   Web of Science ®Google Scholar
• Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, 2nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38:698–710.
   PubMed Web of Science ®Google Scholar
• ESCODD (European Standards Committee on Oxidative DNA Damage). Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 2002;23:2129–2133.
   PubMed Web of Science ®Google Scholar
• ESCODD (European Standards Committee on Oxidative DNA Damage). E. S. C. o. O. D. Inter-laboratory validation of procedures for measuring 8-oxo-7,8-dihydroguanine/ 8-oxo-7,8-dihydro-2′-deoxyguanosine in DNA. Free Radic Res 2002;36:239–245.
   PubMed Web of Science ®Google Scholar
• Riis B. Comparison of results from different laboratories in measuring 8-oxo-2′-deoxyguanosine in synthetic oligonucleotides. Free Radic Res 2002;36:649–659.
   PubMed Web of Science ®Google Scholar
• Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB. Measurement of urinary F-2,-isoprostanes as markers of in vivo lipid peroxidation - a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 1999;272:209–215.
   PubMed Web of Science ®Google Scholar
• Haschke M, Zhang YL, Kahle C, Klawitter J, Korecka M, Shaw LM, Christians U. HPcvfrescf-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma. Clin Chem 2007;53:489–497.
   PubMed Web of Science ®Google Scholar
• Mori T, Croft K, Puddey I, Beilin L. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999;268:117–125.
   PubMed Web of Science ®Google Scholar
• Morrow J, Frei B, Longmire A, Gaziano J, Lynch S, Shyr Y, Strauss W, Oates J, Roberts LN. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198–1203.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J. Key issues in F2-isoprostane analysis. Biochem Soc Trans 2008;36:1060–1065.
   PubMed Web of Science ®Google Scholar
• Wiswedel I, Hirsch D, Kropf S, Gruening M, Pfister E, Schewe T, Sies H. Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans. Free Radic Biol Med 2004;37:411–421.
   PubMed Web of Science ®Google Scholar
• Lykkesfeldt J. Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin Chem 2001;47:1725–1727.
   PubMed Web of Science ®Google Scholar
• Grune T, Siems W, Esterbauer H. Comparison of different assays for malondialdehyde using thiobarbituric acid. Fresen J Anal Chem 1992;343:135–135.
   Google Scholar
• Khoschsorur GA, Winklhofer-Roob BM, Rabl H, Auer T, Peng Z, Schaur RJ. Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 2000;52:181–184.
   Web of Science ®Google Scholar
• Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in pPlasma as measured by lLiquid-chromatographic separation of malondialdehyde thiobarbituric acid adduct. Clin Chem 1987;33:214–220.
   PubMed Web of Science ®Google Scholar
• Londero D, Lo Greco P. Automated high-performance liquid chromatographic separation with spectrofluorometric detection of a malondialdehyde-thiobarbituric acid adduct in plasma. J Chromatogr A 1996;729:207–210.
   PubMed Web of Science ®Google Scholar
• Mateos R, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:76–82.
   PubMed Web of Science ®Google Scholar
• Punchard, N, Kelly F. Free radicals: a practical approach. IRL press at Oxford University Press, Oxford 1996.
   Google Scholar
• Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998;11:1176–1183.
   PubMed Web of Science ®Google Scholar
• Borovic S, Rabuzin F, Waeg G, Zarkovic N. ESCODD (European Standards Committee on Oxidative DNA Damage). Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radic Res 2006 40:809–820.
   PubMed Web of Science ®Google Scholar
• Lang J, Celotto C, Esterbauer H. Quantitative-determination of the lipid-peroxidation product 4-hydroxynonenal by high-performance liquid-chromatography. Anal Biochem 1985; 150:369–378.
   PubMed Web of Science ®Google Scholar
• Yoshino K, Matsuura T, Sano M, Saito S, Tomita I. Fluorometric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides. Chem Pharm Bull (Tokyo) 1986;34:1694–1700.
   PubMed Web of Science ®Google Scholar
• Coolen SA, van Buuren B, Duchateau G, Upritchard J, Verhagen H. Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma. Amino Acids 2005; 29:429–436.
   PubMedGoogle Scholar
• Applegate LA, Scaletta C, Labidi F, Vile GF, Frenk E. Susceptibility of human melanoma cells to oxidative stress including UVA radiation. Int J Cancer 1996;67:430–434.
   PubMed Web of Science ®Google Scholar
• Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelic-Ivanovic Z, Zunic G. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 2007;40:181–187.
   PubMed Web of Science ®Google Scholar
• Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, Harmatz P. The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 2008;45:377–384.
   PubMed Web of Science ®Google Scholar
• Georgiadou P, Iliodromitis E, Varounis C, Mavroidis M, Kolokathis F, Andreadou I, Psarras S, Capetanaki Y, Boudoulas H, Kremastinos DT. Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease. Expert Opin Ther Targ 2008;12:917–920.
   PubMed Web of Science ®Google Scholar
• Kaya C, Erkan AF, Cengiz SD, Dunder I, Demirel OE, Bilgihan A. Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome. Fertil Steril 2009;92:1372–1377.
   PubMed Web of Science ®Google Scholar
• Rattan R, Nayak D. High levels of plasma malondialdehyde, protein carbonyl, and fibrinogen have prognostic potential to predict poor outcomes in patients with diabetic foot wounds: a preliminary communication. Int J Low Extrem Wounds 2008;7:198–203.
   PubMedGoogle Scholar
• Balsam A, El Kossi MM, Lord R, El Nahas AM. Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival. Hemodial Int 2009;13:278–285.
   PubMed Web of Science ®Google Scholar
• Handelman G, Walter M, Adhikarla R, Gross J, Dallal G, Levin N, Blumberg J. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 2001;59:1960–1966.
   PubMed Web of Science ®Google Scholar
• Sircar D, Subbaiah PV. Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation. Clin Chem 2007;53: 251–258.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Gopaul N, Barrow S, Mallet A, Anggard E. Analysis of F2-isoprostanes as indicators of non-enzymatic in vivo lipid peroxidation by gas chromatography: development of a solid-phase extraction procedure. J Chromatogr 1995;667:199–208.
   Web of Science ®Google Scholar
• Borovic S, Cipak A, Meinitzer A, Kejla Z, Perovic D, Waeg G, Zarkovic N. Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells. Redox Rep 2007;12:50–54.
   PubMed Web of Science ®Google Scholar